Adial Pharmaceuticals, Inc. Long-term Purchase Commitment, Amount
Adial Pharmaceuticals, Inc. (ADIL) had Long-term Purchase Commitment, Amount of $3.00 million as of 2023-05-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2025-03-04
- Adial Pharmaceuticals, Inc. long-term purchase commitment, amount for the quarter ending 2023-03-31 was $1.41M.
| Period end | Long-term Purchase Commitment, Amount | Long-term Purchase Commitment, Amount 3 month |
|---|---|---|
| 2023-05-31 | $3.00M 10-K · filed 2025-03-04 | |
| 2023-03-31 | $1.41M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |